Wednesday, June 27, 2007

Genzyme says motion to delay Bioenvision deal withdrawn

(Reuters) - In May, Genzyme agreed to acquire Bioenvision for about
$345 million in cash.





Read more at Reuters.com Government Filings News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)